CVE-2023-5764

Ansible: template injection

Description

A template injection flaw was found in Ansible where a user's controller internal templating operations may remove the unsafe designation from template data. This issue could allow an attacker to use a specially crafted file to introduce templating injection when supplying templating data.

Category

7.1
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.07%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com
Affected: Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 8
Affected: Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 8
Affected: Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 9
Affected: Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 9
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-5764?
CVE-2023-5764 has been scored as a high severity vulnerability.
How to fix CVE-2023-5764?
To fix CVE-2023-5764, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-5764 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-5764 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-5764?
CVE-2023-5764 affects Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 8, Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 8, Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 9, Red Hat Red Hat Ansible Automation Platform 2.4 for RHEL 9.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.